Metabolic Syndrome: Development of the Issue, Main Diagnostic Criteria
Obesity is one of the leading and the most serious risk factors of cardiovascular diseases. Overweight provokes many metabolic and hemodynamic disorders. About 30% of inhabitants of the planet have overweight and prevalence of obesity increases by 10% every 10 years according to the WHO data. The...
Saved in:
| Main Authors: | Yu. N. Belenkov, E. V. Privalova, V. Y. Kaplunova, V. Y. Zektser, N. N. Vinogradova, I. S. Ilgisonis, G. A. Shakaryants, M. V. Kozhevnikova, A. S. Lishuta |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2018-11-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/1766 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vascular Remodeling Markers in Patients with Essential Arterial Hypertension Depending on Presence of Type 2 Diabetes Mellitus
by: Yu. A. Danilogorskaya, et al.
Published: (2019-07-01) -
Hypertrophic Cardiomyopathy and Connective Tissue Dysplasia Syndrome: Comorbidity Variants
by: Yu. N. Belenkov, et al.
Published: (2016-11-01) -
Correlation between markers of fibrosis and myocardial remodeling in patients with various course of hypertrophic cardiomyopathy
by: F. M. Bogatyreva, et al.
Published: (2022-03-01) -
CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION)
by: E. V. Privalova, et al.
Published: (2013-02-01) -
Assesment of Markers of Endothelial Dysfunction and Myocardial Stress in Patients with Hypertrophic Cardyomyopathy
by: F. M. Bogatyreva, et al.
Published: (2021-07-01)